Population
44-year-old woman with no relevant psychiatric history, admitted to a nephrology unit due to acute renal…
Design
Case_report
Follow-up
outpatient follow-up
Key result
A multimodal treatment approach involving electroconvulsive therapy and bromocriptine led to near full remission of symptoms in a 44-year-old woman with atypical neuroleptic malignant syndrome.
Authors
Loading...
May support multimodal ECT-bromocriptine in atypical NMS; leaves open need for controlled validation before broader adoption.
Case Report (n=1)
Neuroleptic malignant syndrome can present atypically and be easily missed; a multimodal treatment approach including ECT should be considered, and post-NMS follow-up is crucial to investigate underlying neurological disorders like Parkinson's disease.
Velosa et al. (2019) conducted a case report in Neuroleptic malignant syndrome (n=1). Electroconvulsive therapy (ECT) and bromocriptine was evaluated on Symptom remission measured by BPRS, BFCRS, and MoCA scores. A multimodal treatment approach involving electroconvulsive therapy and bromocriptine led to near full remission of symptoms in a 44-year-old woman with atypical neuroleptic malignant syndrome.